TRXB Stock Analysis Today
Updated Nov 7, 2026 · trends, key levels, insider activity and news
Is TRXB bullish or bearish today?
Daily trend: Neutral
SEPT signal: Institutional Drive · Leaning Bearish
TRXB trend by timeframe
| Daily | Neutral |
|---|---|
| 4 hour | Leaning Bearish |
| 1 hour | Strong Bearish |
| 15 min | Bullish |
| 5 min | Strong Bearish |
Trends are calculated from price structure and update during market hours.
TRXB support and resistance levels
Resistance (above)
—
Support (below)
—
Upside zones: $14.41 / $14.59 / $14.77
See all levels on the live chart →Insider and institutional activity
Insiders
Buy30-day buys / sells
3 / 030-day net
$3.8MHedge fund holders
0Latest TRXB news and filings
- AnalystBenzinga
Evercore ISI starts Trex Bio coverage with Outperform rating and $28 price target
Evercore ISI Group began covering Trex Bio and gave the shares an Outperform rating. The firm set a $28 price target on the stock.
- AnalystBenzinga
JP Morgan starts Trex Bio coverage with Overweight rating and $20 price target
JP Morgan began covering Trex Bio and rated the shares Overweight. The firm set a $20 price target on the stock.
- AnalystBenzinga
Cantor Fitzgerald starts Trex Bio coverage with Overweight rating
Cantor Fitzgerald began covering Trex Bio and gave the shares an Overweight rating. The call is an analyst opinion on the stock.
- AnalystBenzinga
Stifel starts Trex Bio coverage with Buy rating and $39 price target
Stifel began covering Trex Bio with a Buy rating and set a $39 price target on the shares. The call reflects the analyst's positive view of the company.
- AnalystBenzinga
Wedbush starts Trex Bio coverage with Outperform rating and $30 price target
Wedbush began covering Trex Bio, giving the shares an Outperform rating and setting a $30 price target. The call is an analyst view on the stock rather than company news.
- DealBenzinga
Eli Lilly acquires 5.48M shares of TRex Bio for $12.3M in IPO
Eli Lilly now holds a 19.9% ownership position in TRex Bio after purchasing 5.48 million shares. The $12.3 million purchase was made as part of TRex Bio's initial public offering.
- SEC FilingSECTRex Bio, Inc. filed an insider trading report (Form 4)
Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.
Live TRXB chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is TRXB bullish or bearish today?
TRXB daily trend: Neutral. SEPT signal: Institutional Drive (Leaning Bearish). Updated Nov 7, 2026.
What is TRXB's trend on each timeframe?
Daily: Neutral; 4 hour: Leaning Bearish; 1 hour: Strong Bearish; 15 min: Bullish; 5 min: Strong Bearish.
Are insiders buying or selling TRXB?
Insider signal: Buy. Last 30 days: 3 buys, 0 sells, net $3.8M.
What is the latest news on TRXB?
Nov 3, 2026: Evercore ISI starts Trex Bio coverage with Outperform rating and $28 price target · Nov 3, 2026: JP Morgan starts Trex Bio coverage with Overweight rating and $20 price target · Nov 3, 2026: Cantor Fitzgerald starts Trex Bio coverage with Overweight rating